Guidelines

Good Practice Paper

Haemato-oncology

GPP Management of cardiovascular complications of bruton tyrosine kinase inhibitors

Published:

08/09/2021

Further details

Guideline

General Haematology

Guidelines for the Management of sickle cell disease in pregnancy

Published:

19/08/2021

Further details

Good Practice Paper

General Haematology

GPP Use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders

Published:

18/08/2021

Further details

Good Practice Paper

Transfusion

GPP Cytomegalovirus serological testing in potential allogeneic haematopoietic stem cell transplant recipients

Published:

16/08/2021

Further details

Guideline

Haemato-oncology

Guideline The management of Castleman disease

Published:

02/08/2021

Further details

Guideline

Haemato-oncology

Guidelines for the management of adult myelodysplastic syndromes

Published:

27/06/2021

Further details

Guideline

Haemato-oncology

Guidelines for the diagnosis and evaluation of prognosis of adult myelodysplastic syndromes

Published:

16/06/2021

Further details

Guideline

Haemato-oncology

Guideline on Front‐line management of post‐transplantation lymphoproliferative disorder in adult solid organ recipient patients

Published:

20/04/2021

Further details

Guideline

Haemato-oncology

Guidelines on the diagnosis, investigation and initial treatment of myeloma

Published:

21/03/2021

Further details

Guideline

Haemato-oncology

Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL-V)

Published:

14/10/2020

Further details

Guideline

Transfusion

Guidelines on the use of irradiated blood components

Published:

09/10/2020

Further details

Guideline

Haemato-oncology

Guideline on the diagnosis and management of chronic myeloid leukaemia

Published:

30/07/2020

Further details